E08.351
Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with macular edema
Clinical Classification Guidelines
Medical Intelligence & Overview
Diabetes mellitus is a chronic health condition that affects how your body processes blood sugar (glucose). When diabetes is caused or worsened by another medical condition, it is classified as diabetes due to an underlying disease, such as kidney disease or pancreatic disorders. One serious complication associated with diabetes is diabetic retinopathy, which impacts the eyes and can lead to vision problems if left untreated. Specifically, proliferative diabetic retinopathy with macular edema is a severe form of this complication, characterized by abnormal blood vessel growth in the retina and swelling of the macula, the central part of the retina responsible for sharp vision. Understanding this condition is essential for recognizing its signs, potential causes, and available treatment options.
Causes & Symptoms
Clinical Causes: Prolonged high blood sugar levels from uncontrolled diabetes Underlying conditions such as kidney disease or nerve damage that influence blood sugar control Poor management of diabetes leading to damage to retinal blood vessels Chronic hypertension or high blood pressure often associated with diabetes Genetic factors that predispose individuals to diabetic retinopathy
Key Symptoms: Sudden or gradual vision loss Seeing floaters or spots in the vision Blurred or distorted vision Dark or empty areas in the visual field Difficulty reading or recognizing faces Fluctuating vision, where vision worsens and improves over time
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a comprehensive eye examination by an ophthalmologist, including dilated fundus exams, where drops are used to widen the pupils to inspect the retina and blood vessels. Additional imaging tests such as optical coherence tomography (OCT) or fluorescein angiography can provide detailed images of blood vessels and identify areas of swelling or abnormal vessel growth. Regular eye screening is crucial for individuals with diabetes to detect retinopathy early and initiate timely management.
Treatment Protocols: Managing proliferative diabetic retinopathy with macular edema involves various strategies aimed at halting disease progression and preserving vision. Common treatments include: - Anti-VEGF (vascular endothelial growth factor) injections to reduce abnormal blood vessel growth and fluid leakage - Laser photocoagulation therapy to seal leaking blood vessels and prevent further vision loss - Corticosteroid injections or implants to reduce retinal swelling and inflammation - Tight control of blood sugar, blood pressure, and cholesterol levels to slow disease progression - Regular monitoring and follow-up appointments with eye care specialists In some cases, surgery such as vitrectomy may be necessary if complications like bleeding or retinal detachment occur. It's important to work closely with healthcare providers to manage underlying medical conditions and implement eye-specific treatments effectively.
Clinical Advice & FAQs
Billing Guidance
Is E08.351 a billable ICD-10 code?
Yes, E08.351 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E08.351?
Clinical documentation must specify the nature of Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with macular edema and any associated comorbidities for accurate reporting.
Cite this Clinical Reference